“Treatment for all” means all people with bleeding disorders; including inhibitor patients, rare factor deficiencies and females should have access to safe and effective treatment.
“Treatment for all” means all people with bleeding disorders; including inhibitor patients, rare factor deficiencies and females should have access to safe and effective treatment.